SWP
AMPH icon

Stratos Wealth Partners’s Amphastar Pharmaceuticals AMPH Stock Holding History

Stratos Wealth Partners’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,492
Closed -$241K – 1376
2024
Q1 		$241K Sell
5,492
-1,434
-21% -$74.1K ﹤0.01% 1198
2023
Q4 		$428K Buy
6,926
+2,255
+48% +$118K 0.01% 927
2023
Q3 		$215K Buy
+4,671
New +$255K ﹤0.01% 1139

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stratos Wealth Partners's AMPH Position: Q2 2024 in Review

Stratos Wealth Partners sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2024, closing a stake of 5,492 shares — an estimated $241K sold.

Stratos Wealth Partners first reported a position in AMPH in Q3 2023 and held it in 3 quarters. The position peaked at $428K in Q4 2023. 269 funds tracked by Wall St. Rank hold AMPH as of Q2 2024.

  • Stratos Wealth Partners reported no remaining Amphastar Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Stratos Wealth Partners sold 5,492 Amphastar Pharmaceuticals shares in Q2 2024, an estimated $241K.
  • Stratos Wealth Partners first reported a position in Amphastar Pharmaceuticals in Q3 2023 and held it in 3 quarters.
  • Stratos Wealth Partners's Amphastar Pharmaceuticals position peaked at $428K in Q4 2023.
  • 269 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2024.

Based on Stratos Wealth Partners's 13F filing for Q2 2024, filed 24 Jul 2024.